Review of the Mechanism of Action and Clinical Efficacy of Recombinant Human Hyaluronidase Coadministration with Current Prandial Insulin Formulations

Lignende værker

• Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase
  af: Hompesch, Marcus, et al.
  Udgivet: (2011)
• Accelerating and Improving the Consistency of Rapid-Acting Analog Insulin Absorption and Action for Both Subcutaneous Injection and Continuous Subcutaneous Infusion Using Recombinant Human Hyaluronidase
  af: Muchmore, Douglas B., et al.
  Udgivet: (2012)
• Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase
  af: Morrow, Linda, et al.
  Udgivet: (2013)
• Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
  af: Ivan Ivanovich Dedov, et al.
  Udgivet: (2014-12-01)
• The Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action
  af: Stern, Robert, et al.
  Udgivet: (2006)